Viewing Study NCT02157051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-06-14 @ 8:39 AM
Study NCT ID: NCT02157051
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-22
First Post: 2014-06-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer
Sponsor: University of Washington
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2 Negative Breast Carcinoma View
None Recurrent Breast Carcinoma View
None Stage IIIA Breast Cancer View
None Stage IIIB Breast Cancer View
None Stage IIIC Breast Cancer View
None Stage IV Breast Cancer View
None Stage III Breast Cancer View
Keywords: